2025-05-02 11:19:31
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Norris Medicines Ltd Q3 FY2023 loss at Rs. 20.34 lakhs
Posted On : 2023-02-13 21:31:34( TIMEZONE : IST )
NORRIS MEDICINES LTD. has reported Standalone financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 3.1668 crores during the period ended December 31, 2022 as compared to Rs. 3.0278 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. -0.2034 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. -0.5631 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. -0.20 for the period ended December 31, 2022 as compared to Rs. -0.56 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹3.1668 crs | ₹3.0278 crs |  4.59% |
| Net Profit | ₹-0.2034 crs | ₹-0.5631 crs |  63.88% |
| EPS | ₹-0.20 | ₹-0.56 | 64.29% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.3.1668 crores during the period ended December 31, 2022 as compared to Rs.1.5211 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.-0.2034 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.-0.1872 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.-0.20 for the period ended December 31, 2022 as compared to Rs.-0.19 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹3.1668 crs | ₹1.5211 crs | 108.19% |
| Net Profit | ₹-0.2034 crs | ₹-0.1872 crs |  8.65% |
| EPS | ₹-0.20 | ₹-0.19 | 5.26% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.7.1477 crores during the 9 Months period ended December 31, 2022 as compared to Rs.8.6301 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.-1.2057 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.-1.0307 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.-1.21 for the 9 Months period ended December 31, 2022 as compared to Rs.-1.03 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹7.1477 crs | ₹8.6301 crs |  -17.18% |
| Net Profit | ₹-1.2057 crs | ₹-1.0307 crs | 16.98% |
| EPS | ₹-1.21 | ₹-1.03 | 17.48% |
Shares of NORRIS MEDICINES LTD. was last trading in BSE at Rs. 14.09 as compared to the previous close of Rs. 13.44. The total number of shares traded during the day was 912 in over 29 trades.
The stock hit an intraday high of Rs. 14.09 and intraday low of 12.87. The net turnover during the day was Rs. 12411.00.
